Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis
- 1 January 2004
- journal article
- clinical trial
- Published by Elsevier in Cardiovascular Radiation Medicine
- Vol. 5 (1) , 9-14
- https://doi.org/10.1016/j.carrad.2004.04.002
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Analysis of 1-Year Clinical Outcomes in the SIRIUS TrialCirculation, 2004
- Randomized Trial of 90 Sr/ 90 Y β-Radiation Versus Placebo Control for Treatment of In-Stent RestenosisCirculation, 2002
- Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registryInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Use of localised intracoronary β radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trialThe Lancet, 2002
- Late Arterial Responses (6 and 12 Months) After 32 P β-Emitting Stent PlacementCirculation, 2001
- Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosisJournal of the American College of Cardiology, 2001
- Prevention of Coronary RestenosisCardiology in Review, 1999
- Treatment of In-Stent Restenosis With Excimer Laser Coronary AngioplastyCirculation, 1997
- Results of directional coronary atherectomy during multicenter preapproval testingThe American Journal of Cardiology, 1993
- Management of restenosis within the Palmaz-Schatz coronary stent (the U.S. multicenter experience)The American Journal of Cardiology, 1993